This company is creating a new kind of birth control for men

Contraline says it successfully implanted a contraceptive in four men. Now it has an eye toward FDA approval.

As a student applying to college, Kevin Eisenfrats, cofounder and CEO of Contraline, wrote his application essay on why we need male contraception. Today, the Virginia-based company is announcing that it successfully implanted its contraceptive, ADAM, in four men during a proof-of-concept trial at Epworth Freemasons Hospital in Melbourne, Australia.

Read Full Story